Browse public registers

On 28 January 2015 the ACCC accepted an undertaking (the Undertaking) given by GlaxoSmithKline Plc (GSK) and its subsidiary GlaxoSmithKline Australia Pty Ltd in relation GSK’s proposed acquisition of Novartis AG (Novartis)’s global human vaccine businesses (proposed acquisition).